Evidence map›Paper›PMID 28763063›Full record

ArticleTranslational psychiatry2017

Aripiprazole and Riluzole treatment alters behavior and neurometabolites in young ADHD rats: a longitudinal

F Rizzo, A Abaei, E Nespoli, J M Fegert, B Hengerer, V Rasche, T M Boeckers

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. The Sapap3Translational psychiatry · 2023
    Article
  3. The potential ofPsychopharmacology · 2021
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

F RizzoDepartment of Child and Adolescent Psychiatry and Psychotherapy, Ulm University, Ulm, Germany.
A AbaeiDepartment of Internal Medicine II, AG Experimental Cardiovascular MRI, Small Animal MRI, Ulm University, Ulm, Germany.
E NespoliDepartment of Child and Adolescent Psychiatry and Psychotherapy, Ulm University, Ulm, Germany.
J M FegertDepartment of Child and Adolescent Psychiatry and Psychotherapy, Ulm University, Ulm, Germany.
B HengererBoehringer Ingelheim Pharma GmbH &Co. KG, CNS Diseases, Biberach, Germany.ORCID 0000-0002-7811-9795
V RascheDepartment of Internal Medicine II, AG Experimental Cardiovascular MRI, Small Animal MRI, Ulm University, Ulm, Germany.
T M BoeckersInstitute of Anatomy and Cell Biology, Ulm University, Ulm, Germany.
Universität Ulm · DEBoehringer Ingelheim (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attention deficit hyperactivity disorder (ADHD), Tourette syndrome (TS) as well as obsessive compulsive disorder (OCD) are co-occurring neurodevelopmental diseases that share alterations of frontocortical neurometabolites. In this longitudinal study we investigated the behavioral and neurochemical effects of aripiprazole and riluzole treatment in juvenile spontaneously hypertensive rats (SHR), a model for ADHD. For neurochemical analysis we employed in vivo magnetic resonance spectroscopy (MRS). Spectra from voxels located at the central striatum and prefrontal cortex were acquired postnatally from day 35 to 50. In the SHR strain only, treatments reduced repetitive grooming and climbing behavior. The absolute quantification of cerebral metabolites in vivo using localized

Indexed as

AnimalsAntipsychotic AgentsAripiprazoleAspartic AcidAttention Deficit Disorder with HyperactivityBehavior, AnimalBrainDisease Models, AnimalGlutamic AcidMagnetic Resonance SpectroscopyMaleMotor ActivityNeuroprotective AgentsRatsRats, Inbred WKYRiluzoleAntipsychotic AgentsAripiprazoleAspartic AcidGlutamic AcidNeuroprotective AgentsRiluzole

Identifiers

PMID28763063
PMCPMC5611734
OpenAlexW2740694875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.